The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia

Phase 4 Completed 17 enrolled Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan Yoyogi Sleep Disorder Clinic, Foundation of Sleep and Health Science · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate effects on combination use of Ramelteon in the dose reduction or interruption process of (non-)BZD hypnotics during the dose reduction or interruption algorithm.

Timeline

Start: 2018-02-06
Primary completion: 2019-07-31
Completion: 2020-03-16

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ramelteon	Unknown	8 mg	—

The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia

Summary

Timeline

Drugs

Indications